KCNT1 Epilepsy Foundation Launches Digital Natural History Study In Partnership with Invitae Ciitizen

Today, the KCNT1 Epilepsy Foundation is proud to announce that we have launched a Digital Natural History Study (NHS) in partnership with Invitae. Our goal in establishing this leading-edge program utilizing Invitae’s Ciitizen technology is to accelerate the analysis of patient data for rare disease drug development -- and, in particular, to find treatments and cures for KCNT1. Click to read the press release.